Related Experiment Video
Updated: Jan 11, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Clinical features and current treatment approach to ulcerative proctitis.
1Jill Roberts Center for Inflammatory Bowel Disease, Division of Gastroenterology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Ulcerative proctitis (UP), a subtype of ulcerative colitis (UC), presents unique challenges due to limited research. More high-quality studies are needed to guide effective, personalized treatment strategies for UP patients.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Trial Design
Background:
- Ulcerative colitis (UC) involves chronic colonic inflammation.
- Ulcerative proctitis (UP), confined to the rectum, is a common UC subtype.
- UP faces diagnostic and therapeutic challenges with limited specific research.
Purpose of the Study:
- To review the current state of ulcerative proctitis (UP) research.
- To identify gaps in knowledge and guide future research directions.
- To emphasize the need for evidence-based management strategies for UP.
Main Methods:
- Literature review focusing on ulcerative proctitis (UP) diagnosis and treatment.
- Analysis of existing randomized controlled trials (RCTs) and their limitations regarding UP.
- Examination of diagnostic criteria and current therapeutic approaches for UP.
Main Results:
- UP research is hindered by variable study designs, definitions, and outcomes.
- Randomized controlled trials (RCTs) often exclude UP patients, limiting evidence.
- Efficacy of first-line treatments like 5-ASA and corticosteroids is established, but advanced therapies lack UP-specific data.
Conclusions:
- There is a critical need for standardized guidelines and targeted research for UP.
- Personalized treatment strategies and regular surveillance are essential for UP management.
- Future studies should focus on defining treatment targets and evaluating novel therapies for UP.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Constipation-Predominant IBS

